Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Aradigm Receives FDA Clearance For Phase IIb Clinical Trial Of Inhaled Liposomal Ciprofloxacin To Treat Bronchiectasis
Aradigm Corporation (OTCBB:ARDM) (the "Company") announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The initial clinical protocol under this IND is an international, randomized, double-blind, placebo-controlled Phase IIb study designed to evaluate the Company"s inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis (BE). This orphan drug condition is a chronic severe respiratory disease and there is currently no drug specifically approved for its treatment in the U.S.
generic viagra online
Poniard Rally To Continue: Strong Efficacy And Safety Data From Picoplatin
Poniard announced positive Phase II data from its two trials in CRC and CRPC with picoplatin this morning, including efficacy that was comparable to the current standard of care, with a significantly improved safety profile. We believe that these data provide further evidence of picoplatin"s favorable efficacy and safety profile in two more large oncology markets, in addition to SCLC, and position picoplatin as a platform treatment that can provide solutions in multiple oncology settings. We believe that given these data from CRC and CRPC, in addition to the anticipated Phase III SPEAR data in SCLC, will attract the interest of multiple players and we expect that Poniard will be able to at least secure a large pharma partnership sometime this summer, unless a company like Sanofi (SNY Not Rated), Takeda (TKD Not rated), or Bristol-Myers Squibb (BMY Not Rated) decide to step in and acquire the whole company, for rights to both the IV and oral version of picoplatin.
News of the day
Skills For Catheter Insertion Improved By Simulation Training
New technology allows student doctors to practice operations and other procedures on simulators before trying them out on real patients, just as pilots practice for emergencies on aircraft simulators. Medical educators feel that this will increase patient safety, by avoiding first-time mistakes being made on live patients. But does education by simulation actually work? Can doctors learn new skills on simulators instead of on humans?
Diagnostics

MEDEC Commends The Ontario Government's Decision To Make PET Scans More Accessible To Patients In The Province

MEDEC - Canada"s Medical Technology Companies - applauds the Ontario Government for its recent decision to add Positron Emission Tomography (PET) Technology to the services covered by the Ontario Health Insurance Plan (OHIP) thereby ensuring that Ontarians have access to PET technology. MEDEC Vice President Corporate Affairs, Lawrence Sereacki praised the actions of the Ontario government, noting that this is an opportune time for the government to modify its PET policy to help resolve the medical isotope dilemma and enhance the expeditious review and adoption of new technology for the benefit of patients. He added that MEDEC looks forward to working with the government and acting as a re to ensure smooth implementation of PET access for Ontarians. "PET scan technology is well recognized by Health Canada and others around the world" he said. "We are pleased that the government has decided to make this modern medical technology available to a wide cross section of Ontarians. Historically, Ontario had taken a decision to restrict PET scans. MEDEC had repeatedly stressed in the past that this restrictive access to PET technology has disadvantaged Ontario residents who needed access to PET scans for appropriate diagnosis and treatment and created a disparity between access to health care in Ontario versus other provinces. While applauding the province"s new step towards improving access to health technologies, MEDEC sees the need for the Ontario government to make additional changes to expeditiously assess and make modern technology more rapidly available to Ontario patients. Additionally, MEDEC recommends that the Ontario Government set up a Medical Device Technology Fund to finance technologies recommended by the Ontario Health Technology Advisory Committee (OHTAC) to improve patient access to advanced medical technologies and ensure hospitals and healthcare facilities offer advanced technologies that can save lives. MEDEC


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009